Takeda Pharmaceutical Co. Ltd (TAK)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 859 |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q1 2026 | |||||
| ≡ | Richard Pzena - Pzena Investment Management | Add 37.49% | 7,733 | 0.00 | |
| Q4 2025 | |||||
| ≡ | Richard Pzena - Pzena Investment Management | Buy | 20,627 | 0.00 | |
| Q1 2024 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Add 7.38% | 99,263 | 0.04 | |
| Q4 2023 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Add 8.14% | 101,336 | 0.04 | |
| Q3 2023 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Add 11.04% | 123,725 | 0.05 | |
| Q1 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 352.38% | 1,356,666 | 0.37 | |
| ≡ | Seth Klarman - Baupost Group | Buy | 10,669,021 | 1.88 | |
| Q4 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 385,000 | 0.10 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.